
Merck's Covid-19 pill is great news but may not be a game-changer
CNN
A new approach to managing the Covid-19 pandemic now could be on the table: antiviral pills. On Friday, Merck and Ridgeback Biotherapeutics said their results (still not peer-reviewed) demonstrate their novel drug molnupiravir cut in half the rate of hospitalization and death in persons with mild to moderate disease. If authorized by the US Food and Drug Administration for emergency use, the pill would become the first oral medicine to fight viral infection for Covid-19.
More Related News

Oklahoma’s governor picks energy executive Alan Armstrong to fill US Senate seat through end of year
Oklahoma’s governor on Tuesday appointed energy executive Alan Armstrong to serve in the US Senate through the end of the year and finish the term of Republican Markwayne Mullin, the new homeland security secretary.












